[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IS5684A - Ímídasópýridínafleiður sem hindra magasýruflæði - Google Patents

Ímídasópýridínafleiður sem hindra magasýruflæði

Info

Publication number
IS5684A
IS5684A IS5684A IS5684A IS5684A IS 5684 A IS5684 A IS 5684A IS 5684 A IS5684 A IS 5684A IS 5684 A IS5684 A IS 5684A IS 5684 A IS5684 A IS 5684A
Authority
IS
Iceland
Prior art keywords
gastric acid
acid flow
imidazopyridine derivatives
inhibit gastric
inhibit
Prior art date
Application number
IS5684A
Other languages
English (en)
Inventor
Amin Kosrat
Dahlström Mikael
Nordberg Peter
Starke Ingemar
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS5684A publication Critical patent/IS5684A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS5684A 1998-04-29 2000-10-25 Ímídasópýridínafleiður sem hindra magasýruflæði IS5684A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801526A SE9801526D0 (sv) 1998-04-29 1998-04-29 New compounds
PCT/SE1999/000663 WO1999055706A1 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion

Publications (1)

Publication Number Publication Date
IS5684A true IS5684A (is) 2000-10-25

Family

ID=20411154

Family Applications (2)

Application Number Title Priority Date Filing Date
IS5683A IS5683A (is) 1998-04-29 2000-10-25 Ímídasópýridínafleiður sem hindra magasýruflæði
IS5684A IS5684A (is) 1998-04-29 2000-10-25 Ímídasópýridínafleiður sem hindra magasýruflæði

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS5683A IS5683A (is) 1998-04-29 2000-10-25 Ímídasópýridínafleiður sem hindra magasýruflæði

Country Status (34)

Country Link
US (2) US6313136B1 (is)
EP (4) EP1073657B1 (is)
JP (2) JP3692034B2 (is)
KR (3) KR100595806B1 (is)
CN (2) CN1174980C (is)
AR (2) AR015768A1 (is)
AT (4) ATE372340T1 (is)
AU (2) AU769108B2 (is)
BR (2) BR9909995B1 (is)
CA (2) CA2329921A1 (is)
CZ (2) CZ293977B6 (is)
DE (4) DE69937076T2 (is)
DK (2) DK1073657T3 (is)
EE (2) EE04916B1 (is)
ES (2) ES2252975T3 (is)
HK (5) HK1033457A1 (is)
HU (2) HUP0102425A3 (is)
ID (2) ID26819A (is)
IL (4) IL139297A0 (is)
IS (2) IS5683A (is)
MY (2) MY121389A (is)
NO (2) NO317262B1 (is)
NZ (2) NZ507639A (is)
PL (2) PL343797A1 (is)
RU (2) RU2235725C2 (is)
SA (2) SA99200065B1 (is)
SE (1) SE9801526D0 (is)
SI (1) SI1073656T1 (is)
SK (2) SK285768B6 (is)
TR (4) TR200003176T2 (is)
TW (2) TWI250159B (is)
UA (2) UA66846C2 (is)
WO (2) WO1999055706A1 (is)
ZA (2) ZA200005797B (is)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
US6900324B2 (en) 2000-09-07 2005-05-31 Astrazeneca Ab Process for preparing a substituted imidazopyridine compound
SE0003186D0 (sv) 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
WO2002064121A1 (en) * 2001-02-13 2002-08-22 Astrazeneca Ab Novel modified released formulation
EP1370261A2 (en) * 2001-03-08 2003-12-17 AstraZeneca AB New use
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
AU2003295332B2 (en) 2002-09-19 2007-01-18 Merck Sharp & Dohme Corp. Imidazopyridines as cyclin dependent kinase inhibitors
NZ540504A (en) 2002-11-19 2007-12-21 Altana Pharma Ag 8-Substituted imidazopyridines for the treatment of gastrointestinal disorders
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
PT2476667E (pt) * 2003-02-26 2014-09-18 Sugen Inc Compostos de aminoheteroarilo como inibidores da proteína quinase
BRPI0406427B8 (pt) 2003-03-10 2021-05-25 Astrazeneca Ab processo para a preparação de roflumilast
SE525349C2 (sv) * 2003-06-23 2005-02-08 Volvo Penta Ab Utombordsdrev för båtar
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005041961A1 (en) * 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
WO2005070927A2 (en) * 2004-01-26 2005-08-04 Altana Pharma Ag 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006064339A1 (en) * 2004-12-17 2006-06-22 Pfizer Japan Inc. Chromane derivatives useful as acid pump antagonists
ES2421916T3 (es) 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
WO2006101455A1 (en) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
AR055321A1 (es) * 2005-03-24 2007-08-15 Glaxo Group Ltd Compuestos de imidazopiridina uso para a fabricacion de un medicamento para el tratamiento o profilaxis de enfermedades o trastornos en los que se requiere un antagonista de una bomba de acido y composicion farmaceutica que lo comprende
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
WO2007066185A2 (en) 2005-12-05 2007-06-14 Pfizer Products Inc. Polymorphs of a c-met/hgfr inhibitor
DK1959955T3 (da) 2005-12-05 2011-02-07 Pfizer Prod Inc Fremgangsmåde til behandling af abnorm cellevækst
BRPI0708808A2 (pt) * 2006-03-17 2011-06-14 Raqualia Pharma Inc Derivados de cromano
US8728527B2 (en) 2006-07-24 2014-05-20 Luminus Biosciences, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
EP1974729A1 (en) * 2007-03-28 2008-10-01 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
WO2009122435A2 (en) * 2008-03-31 2009-10-08 Council Of Scientific & Industrial Research A simultaneous method for the preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
AU2014201644B2 (en) * 2008-12-03 2015-05-21 Cinclus Pharma Holding AB (publ) Imidazopyridine derivatives which inhibit the secretion of gastric acid
FI20086158A0 (fi) * 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
RU2586276C2 (ru) * 2009-07-09 2016-06-10 Раквалиа Фарма Инк. Антагонист кислотного насоса для лечения заболеваний, связанных с патологическим нарушением моторики желудочно-кишечного тракта
JP6492071B2 (ja) * 2013-06-25 2019-03-27 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 脊髄性筋萎縮を処置するための化合物
KR102430072B1 (ko) 2013-12-16 2022-08-10 에이비에스 디벨롭먼트 원 인코포레이티드 P2x3 및/또는 p2x2/3 화합물 및 방법
CN106459036B (zh) * 2014-03-24 2021-07-16 艾科尔公司 制备3-(3-(4-(1-氨基环丁基)苯基)-5-苯基-3H-咪唑并[4,5-b]吡啶-2-基)吡啶-2-胺的方法
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko) 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
EP3749697A4 (en) 2018-02-05 2021-11-03 Bio-Rad Laboratories, Inc. CHROMATOGRAPHY RESIN WITH LIGAND MIXED MODE ANIONIC / HYDROPHOBIC EXCHANGE
KR102706151B1 (ko) * 2018-04-10 2024-09-13 바이엘 악티엔게젤샤프트 2,6-디알킬페닐아세트산을 제조하는 방법
RU2732297C2 (ru) * 2018-11-14 2020-09-15 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные нестероидных противовоспалительных средств
US20220362223A1 (en) 2019-11-04 2022-11-17 Cinclus Pharma Holding AB Oral formulation of x842
WO2023079093A1 (en) 2021-11-05 2023-05-11 Cinclus Pharma Holding AB (publ) Polymorphs of the mesylate salt of linaprazan glurate
EP4426694A1 (en) 2021-11-05 2024-09-11 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법
WO2024149833A1 (en) 2023-01-11 2024-07-18 Cinclus Pharma Holding AB (publ) Polymorphs of the maleic acid salt of linaprazan glurate
WO2024149834A1 (en) 2023-01-11 2024-07-18 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrobromide salt of linaprazan glurate
WO2024161317A1 (ko) * 2023-02-01 2024-08-08 제일약품주식회사 약학적 제제, 이의 제조 방법, 및 정제용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound

Also Published As

Publication number Publication date
CA2329922C (en) 2006-04-11
EE200000626A (et) 2002-04-15
DE69927803D1 (de) 2006-03-02
IL139200A0 (en) 2001-11-25
ZA200005797B (en) 2002-01-18
IS5683A (is) 2000-10-25
DE69937077D1 (de) 2007-10-18
JP2002513025A (ja) 2002-05-08
JP2002513024A (ja) 2002-05-08
JP3883383B2 (ja) 2007-02-21
EE200000664A (et) 2002-04-15
EP1491542B1 (en) 2007-09-05
DE69937077T2 (de) 2008-05-29
HUP0102313A2 (hu) 2001-12-28
NO20005451D0 (no) 2000-10-27
HK1033317A1 (en) 2001-08-24
UA67769C2 (uk) 2004-07-15
EP1491542A3 (en) 2005-01-05
ES2252975T3 (es) 2006-05-16
ES2249913T3 (es) 2006-04-01
HUP0102425A3 (en) 2002-12-28
HK1071139A1 (en) 2005-07-08
CZ293977B6 (cs) 2004-09-15
CZ20003982A3 (cs) 2001-02-14
SK285768B6 (sk) 2007-07-06
TW490466B (en) 2002-06-11
CN1174980C (zh) 2004-11-10
HK1036981A1 (en) 2002-01-25
WO1999055706A9 (en) 2000-03-16
TR200102612T2 (tr) 2002-06-21
DK1073656T3 (da) 2006-01-16
EE04916B1 (et) 2007-10-15
RU2238271C2 (ru) 2004-10-20
MY121389A (en) 2006-01-28
BR9909995A (pt) 2000-12-26
NO318203B1 (no) 2005-02-14
CN1307577A (zh) 2001-08-08
EE04676B1 (et) 2006-08-15
SA99200064B1 (ar) 2006-10-11
KR20010043133A (ko) 2001-05-25
TWI250159B (en) 2006-03-01
SE9801526D0 (sv) 1998-04-29
NO20005451L (no) 2000-12-27
KR20010043134A (ko) 2001-05-25
BR9909996B1 (pt) 2010-08-24
EP1073657B1 (en) 2005-12-07
AU769108B2 (en) 2004-01-15
KR20050121760A (ko) 2005-12-27
PL343797A1 (en) 2001-09-10
EP1073656B1 (en) 2005-10-19
EP1491543B1 (en) 2007-09-05
DE69937076T2 (de) 2008-05-29
ATE372339T1 (de) 2007-09-15
CN1165535C (zh) 2004-09-08
AU4300699A (en) 1999-11-16
DE69928792T2 (de) 2006-07-20
JP3692034B2 (ja) 2005-09-07
AR015769A1 (es) 2001-05-16
DE69928792D1 (de) 2006-01-12
NO20005450L (no) 2000-12-22
ATE372340T1 (de) 2007-09-15
EP1073657A1 (en) 2001-02-07
CZ292567B6 (cs) 2003-10-15
UA66846C2 (uk) 2004-06-15
ATE312101T1 (de) 2005-12-15
KR100595806B1 (ko) 2006-07-03
CA2329922A1 (en) 1999-11-04
IL139297A (en) 2007-06-03
ID26819A (id) 2001-02-15
AU4300799A (en) 1999-11-16
WO1999055706A1 (en) 1999-11-04
CN1306533A (zh) 2001-08-01
NO20005450D0 (no) 2000-10-27
EP1073656A1 (en) 2001-02-07
BR9909995B1 (pt) 2010-07-13
EP1491542A2 (en) 2004-12-29
SI1073656T1 (sl) 2006-02-28
SK14912000A3 (sk) 2001-06-11
DE69937076D1 (de) 2007-10-18
NZ507638A (en) 2003-10-31
CA2329921A1 (en) 1999-11-04
TR200102728T2 (tr) 2002-06-21
EP1491543A1 (en) 2004-12-29
NO317262B1 (no) 2004-09-27
SK14922000A3 (sk) 2001-06-11
HUP0102313A3 (en) 2002-10-28
IL139297A0 (en) 2001-11-25
US6313137B1 (en) 2001-11-06
DK1073657T3 (da) 2006-03-13
PL343801A1 (en) 2001-09-10
AR015768A1 (es) 2001-05-16
CZ20003981A3 (cs) 2001-03-14
AU769190B2 (en) 2004-01-22
ID27530A (id) 2001-04-12
TR200003149T2 (tr) 2001-03-21
US6313136B1 (en) 2001-11-06
RU2235725C2 (ru) 2004-09-10
NZ507639A (en) 2004-01-30
DE69927803T2 (de) 2006-07-06
BR9909996A (pt) 2000-12-26
KR100650472B1 (ko) 2006-11-28
IL139200A (en) 2010-04-29
TR200003176T2 (tr) 2001-03-21
SA99200065A (ar) 2005-12-03
WO1999055705A1 (en) 1999-11-04
MY121379A (en) 2006-01-28
HK1033457A1 (en) 2001-08-31
KR100595805B1 (ko) 2006-07-03
HUP0102425A2 (hu) 2001-11-28
SA99200065B1 (ar) 2006-11-07
HK1036984A1 (en) 2002-01-25
ZA200005796B (en) 2002-01-18
PL195000B1 (pl) 2007-07-31
ATE307130T1 (de) 2005-11-15

Similar Documents

Publication Publication Date Title
IS5683A (is) Ímídasópýridínafleiður sem hindra magasýruflæði
DK1071420T3 (da) Indolyl-3-glyoxylsyrederivater med antitumorvirkning
HK1064670A1 (en) Pyridine-3-carboxylic acid derivatives
NO20066017L (no) Azaindoler
DK1086101T3 (da) Beta-carbolinforbindelser
IL139470A0 (en) Oxyiminoalkanoic acid derivatives
IS5818A (is) Alkýnýl-setnar kínólín-2-ón afleiður gagnlegar sem miðlar gegn krabbameini
ATE243807T1 (de) Rohrverbindung
DE69909348D1 (de) Rohrverbindung
PL345794A1 (en) Aminomethylcarboxylic acid derivatives
ATE305470T1 (de) Naphthyridinverbindungen
DE69931773D1 (de) Rohrverbindung
HK1054038A1 (en) Substituted n-benzyl-indol-3-yl gloyoxylic acid derivatives having an antitumural effect
IS5562A (is) Nýjar díhýdroxýhexanósýru afleiður
DE59914584D1 (de) Organisch-anorganischer Mörtel
NO20010508D0 (no) Rörforbindelse
DE60011802D1 (de) Rohrverbindung
DE60009129D1 (de) Additivkonzentrat
IS4485A (is) Efnasambönd sem hindra flæði magasýru
DE69905397D1 (de) Selektive inhibitoren des mmp-12
DE59906407D1 (de) Lösbare Rohrverbindung
DE50015100D1 (de) Rohrleitungsverbindung
ATA81298A (de) Rohrverbindung
ATA45498A (de) Rohrverbindung
FI19991814A (fi) Virtausohjain